A Case of Metastatic Pigmented Basal Cell Carcinoma With Low Tumor Mutation Burden Responding to Nivolumab

Related Experiment Video

Updated: Sep 14, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.6K

Yurie Matsuzaki1, Jiro Uehara1, Tomoki Shibahara1

  • 1Department of Dermatologic Oncology, Center Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

The Journal of Dermatology
|July 24, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
AsianPTCH1TMBmetastatic basal cell carcinomanivolumab

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.0K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662